Related by context. All words. (Click for frequent words.) 81 HbA1c levels 78 A1c levels 75 hemoglobin A1c levels 74 HbA1c 73 A1C 73 HbA 1c 73 A1c 73 Hb A1C 73 HbA1C 72 glycated hemoglobin levels 72 baseline HbA1c 71 hemoglobin A1c HbA1c 70 hemoglobin A1C 70 hemoglobin A1c 69 serum potassium 69 blood glucose levels 68 serum urate 68 HbA 1c levels 68 fasting plasma glucose 68 glycosylated hemoglobin 68 serum uric acid 68 glycated hemoglobin 68 antihypertensive medications 67 baseline A1C 67 glycosylated hemoglobin HbA1c 67 fasting blood glucose 67 HbA1C levels 67 sUA 67 serum creatinine levels 66 serum urate levels 66 LDL C 66 ejection fractions 66 serum phosphorus 66 glycated hemoglobin HbA1c 66 urate levels 65 LDL cholesterol levels 65 serum calcium 65 HbA 1C 65 #mmHg [001] 65 alanine aminotransferase ALT 64 #/#mmHg 64 triglyceride levels 64 fasting glucose levels 64 HBeAg seroconversion 64 plasma glucose levels 64 serum phosphate 64 serum calcium levels 64 uric acid levels 64 serum phosphate levels 64 mm Hg systolic 64 adiponectin levels 63 mmHg 63 NPH insulin 63 hydroxyvitamin D levels 63 thiazide diuretics 63 systolic blood pressure 63 blood Phe levels 63 Triglyceride levels 63 mmol l 63 nonfasting triglyceride levels 63 fasting plasma glucose FPG 63 Hb A1c 63 serum sodium 63 systolic BP 63 glycemia 63 plasma HCV RNA 63 #.#/#.# mmHg [001] 63 mm Hg 62 cTnT levels 62 platelet inhibition 62 albumin excretion 62 A1Cs 62 CDAI score 62 proteinuria 62 platelet reactivity 62 undetectable viral 62 neutrophil counts 62 triglyceride concentration 62 hypertensive patients 62 binary restenosis 62 sUA levels 62 ACR# response 62 fructose diet 62 fasting glucose 62 arterial stiffness 62 elevated LDL cholesterol 62 eGFR 62 fasting insulin 62 troponin T 62 #mmHg [002] 62 mealtime insulin 62 antihypertensive medication 62 creatinine levels 61 nocturnal hypoglycaemia 61 dapagliflozin plus 61 complete cytogenetic response 61 PASI scores 61 LVEF 61 HBV DNA levels 61 serum testosterone 61 fasting triglyceride levels 61 PSA nadir 61 serum glucose 61 plasma glucose 61 sustained virological response 61 OADs 61 elevated creatinine 61 antihypertensive therapy 61 sustained virologic response 61 #mg/dL [001] 61 magnesium intake 61 lipid parameters 61 glycosylated hemoglobin levels 61 mg dL 61 biphasic insulin aspart 61 Crohn Disease Activity 61 albuminuria 61 insulin glargine 61 bad cholesterol LDL 61 LDL Cholesterol 61 microalbuminuria 61 dose colchicine 61 NovoLog ® Mix 61 hypoglycemic episodes 61 blood sugar 61 CrCl 61 mm Hg diastolic 61 -#.# mg dL [002] 61 mL/min/#.# m 2 61 #mg/dL [002] 61 homocysteine levels 61 hemoglobin concentrations 61 PSADT 61 SHBG levels 61 LDL cholesterol 61 microvascular complications 61 HDL C 61 lispro 61 allopurinol 61 Hemoglobin A1c 60 MMSE scores 60 albumin excretion rate 60 incontinence episodes 60 statin monotherapy 60 blood glucose concentrations 60 postprandial glucose 60 serum triglyceride levels 60 HOMA IR 60 lipid levels 60 corticosteroid dose 60 oral antidiabetic medication 60 asymptomatic carotid stenosis 60 mEq L 60 systolic dysfunction 60 advanced adenomas 60 NATRECOR R 60 oral allopurinol 60 glycemic control 60 serum HCV RNA 60 hypertensives 60 gout flares 60 Ejection Fraction 60 glimepiride 60 RBP4 levels 60 serum potassium levels 60 hsCRP 60 elevated uric acid 60 antihypertensive drugs 60 certolizumab 60 pulmonary capillary wedge 60 μg dL 60 serum phosphorus levels 60 cholesterol LDL C 60 Index CDAI score 60 mmHg systolic 60 iPTH 60 nondiabetic patients 60 HDL Cholesterol 59 serum IGF 59 serum LDL cholesterol 59 postoperative mortality 59 atherogenic lipids 59 #mg doses [002] 59 intima media thickness 59 leukocyte count 59 urinary oxalate 59 oxycodone CR 59 oral antidiabetes 59 aminotransferases 59 lowering systolic blood 59 ejection fraction 59 nicardipine 59 Fasting glucose 59 glomerular filtration rate 59 mmHg diastolic 59 serum vitamin D 59 blood glucose 59 serum phosphorous 59 ng dL 59 blood Phe 59 triglyceride concentrations 59 nondiabetics 59 EDSS scores 59 lipid lowering medications 59 serum HBV DNA 59 insulin detemir 59 systolic blood pressures 59 atherogenic dyslipidemia 59 Personal CGM 59 BENICAR 59 hypokalemia 59 Lantus ® 59 CK # plasma concentrations 59 elevated CRP 59 hs CRP 59 annualized relapse 59 subclinical hypothyroidism 59 mg dl 59 gastric pH 59 detemir 59 serum cholesterol 59 mucosal healing 59 DAS# [002] 59 plasma triglycerides 59 hypoglycemic events 59 glulisine 59 mean baseline HbA1c 59 undetectable viral load 59 intensive statin therapy 59 thyrotropin levels 59 x ULN 59 elevated triglyceride levels 59 hsCRP levels 59 rimonabant #mg 59 fluticasone salmeterol 59 improves glycemic 59 fat vegan diet 59 irbesartan 59 virologic response 59 recurrent VTE 59 baseline serum creatinine 59 plus methotrexate 59 atorvastatin #mg 59 #.#mmol L [002] 58 LDL 58 OGTT 58 severe hypoglycaemia 58 lowering blood glucose 58 lumbar spine BMD 58 pioglitazone 58 macrovascular events 58 urate lowering therapy 58 primary hypercholesterolemia 58 diastolic blood pressures 58 serum uric acid sUA 58 serum PSA 58 benazepril 58 serum PTH 58 glargine 58 Hb levels 58 intraocular pressure IOP 58 ATACAND 58 Intraocular pressure 58 intraocular pressure 58 triacylglycerol concentrations 58 achieved ACR# 58 Welchol 58 mg simvastatin 58 diastolic BP 58 aldosterone antagonist 58 metabolic parameters 58 BENICAR HCT 58 metformin sulphonylurea 58 adalimumab 58 paricalcitol 58 log# copies mL 58 β blockers 58 intensity aerobic exercise 58 homocysteine concentrations 58 IU mL 58 peginterferon alfa 2a 58 serum lipid levels 58 folate intake 58 tapentadol ER 58 exhaled nitric oxide 58 undetectable HCV RNA 58 alanine aminotransferase 58 liver histology 58 glycemic diet 58 transferrin saturation 58 dietary sodium intake 58 lowest tertile 58 severe exacerbations 58 elevated ALT 58 platelet counts 58 μmol L 58 pCR 58 C reactive protein 58 serum triglycerides 58 acarbose 58 MS relapses 58 oral antidiabetic drugs 58 ARB telmisartan 58 log# IU mL 58 serum clusterin levels 58 diastolic pressure 58 CVD mortality 58 dose cytarabine 58 lispro alone 58 sodium intake 58 calculated creatinine clearance 58 lipid lowering agents 57 retinal thickness 57 lipid lowering therapy 57 DASH diet 57 Ishak fibrosis score 57 glomerular filtration 57 inhaled steroid 57 estimated glomerular filtration 57 hyperphenylalaninemia HPA due 57 serum homocysteine 57 Fibrates 57 severe hypoglycemia 57 lipid profiles 57 creatinine clearance 57 adjunctive placebo 57 elevated IOP 57 poor metabolizers 57 urine albumin 57 FEV1 57 creatinine ratio 57 Pred Forte 57 tolterodine ER 57 hemoglobin levels 57 non aspirin NSAIDs 57 exhaled NO 57 AZOR 57 mmol L. 57 apnea hypopnea index 57 estimated GFR 57 systolic pressure 57 angiotensin converting enzyme inhibitors 57 Score DAS# 57 cardiovascular mortality 57 virologic failure 57 morphometric vertebral fractures 57 RLS symptoms 57 hip BMD 57 alemtuzumab treated 57 % Confidence Interval 57 bezafibrate 57 dosing frequency 57 CLA supplementation 57 nmol L 57 CMV infection 57 lopinavir r arm 57 QTcF 57 EDSS score 57 achieved statistical significance 57 lung function 57 tHcy 57 APTIVUS r 57 T2DM 57 reinfarction 57 solifenacin 57 nocturnal hypoglycemia 57 intact parathyroid hormone 57 LANTUS R 57 lipid lowering drugs 57 prednisone prednisolone 57 steroid dexamethasone 57 adenoma recurrence 57 Victoza R 57 density lipoprotein HDL cholesterol 57 fraction LVEF 57 hyperkalemia 57 blood phenylalanine Phe 57 colorectal adenoma 57 #.#ng/ml 57 hypoglycemia 57 arterial thromboembolic events 57 rosuvastatin #mg 57 trans fat intake 57 drug depresses breathing 57 statin therapy 57 NYHA class 57 sodium excretion 57 elevated blood glucose 57 tirofiban 57 XIENCE V PROMUS Stent 57 lymphocyte counts 57 viral suppression 57 macrovascular 57 sulphonylurea 57 EpCAM expression 57 g dL 57 #.#mg/dL 57 salivary flow 57 systolic hypertension 57 CIMZIA ™ 57 apolipoprotein B 57 serum concentrations 57 serum folate 57 Cortisol levels 57 polyp recurrence 57 Knodell necroinflammatory score 57 seropositive patients 57 renal dysfunction 57 pharmacological intervention 57 #mg dose [002] 57 serum creatinine 57 dose atorvastatin 57 adrenal function 57 complete cytogenetic 57 antidiabetic medication 56 ng ml 56 cardiorespiratory fitness 56 nondiabetic 56 cholesterol HDL 56 PRADAXA #mg 56 insulin lispro 56 per deciliter mg 56 thiazides 56 muscle protein synthesis 56 glucose lowering 56 metformin sulfonylurea 56 milligrams deciliter 56 receiving Vectibix monotherapy 56 CPAP adherence 56 T1DM 56 #mg/day [001] 56 HDL cholesterol 56 dietary sodium 56 PREZISTA r arm 56 density lipoprotein cholesterol 56 diabetes mellitus DM 56 NIHSS 56 antibody titer 56 basal bolus therapy 56 mmol L 56 carotid IMT 56 symptomatic VTE 56 PREZISTA r 56 CK MB 56 aspartate aminotransferase AST 56 vildagliptin 56 serum CRP 56 dose ritonavir 56 MADRS score 56 ACE inhibitor ramipril 56 plasma urate 56 protein excretion 56 urinary albumin 56 mcg mL 56 Fasting plasma glucose 56 RBP4 56 mean serum phosphorus 56 ADHD symptoms 56 HBV DNA 56 CD4 counts 56 + PH# 56 titrated glipizide 56 NNT = 56 virological response 56 concomitant medications 56 pyridostigmine 56 serum cortisol 56 #.#mmol L [001] 56 asthma exacerbations 56 mIU L 56 plasma homocysteine 56 ACTEMRA TM 56 viral load 56 candesartan 56 urinary protein 56 elevated triglycerides 56 mg BID 56 log# reduction 56 prolactin levels 56 normotensive 56 macroalbuminuria 56 dyslipidaemia 56 HCV RNA 56 MELD scores 56 g dl 56 overt nephropathy 56 nonvertebral fractures 56 postprandial blood glucose 56 CIMZIA TM 56 IOP lowering 56 pg ml 56 salt intake 56 moderate renal impairment 56 ruboxistaurin 56 HDL LDL ratio 56 severe renal impairment 56 c reactive protein 56 infarct size 56 FOLFOX4 56 glyburide 56 HAM D# scores 56 uncontrolled asthma 56 potassium intake 56 biochemical relapse 56 luminal diameter 56 folic acid intake 56 copies mL 56 Index CDAI 56 Montgomery Asberg Depression 56 mL/min/#.# m2 56 dose clopidogrel 56 left ventricular ejection 56 fructose intake 56 CCyR 56 reflux symptoms 56 nondepressed 56 impaired fasting glucose 56 low dose Iluvien 56 pramlintide 56 ng mL 56 ALT elevation 56 Viral load 56 mmol liter 56 mg dose 56 GERD symptoms 56 MoxDuo TM IR 56 Prostate Specific Antigen PSA 56 #.#mmol l [002] 56 evaluable subjects 56 arterial thickening 56 D dimer 56 clinically meaningful improvements 56 FeNO 56 urinary cortisol 56 prescribed beta blocker 56 8 OHdG 55 #.#mmHg 55 carbohydrate intake 55 laboratory abnormalities 55 triglycerides 55 EDARBI 55 arterial elasticity 55 hepatic glucose production 55 low dose ritonavir 55 octreotide LAR 55 vaginal progesterone gel 55 abdominal adiposity 55 cardiovascular morbidity 55 Score IPSS 55 Pioglitazone 55 depressive symptoms 55 aldosterone antagonists 55 4mg/kg 55 mg TID 55 basal cell nevus syndrome 55 calcium intake 55 #OHD levels 55 definite stent thrombosis 55 revascularization procedures 55 abacavir lamivudine 55 kidney function 55 Endothelial function 55 Victoza ® 55 Severe hypoglycemia 55 pg mL 55 Sitagliptin 55 cystatin C 55 unfractionated heparin 55 Lupuzor ™ 55 inflammatory biomarkers 55 ACR Pedi 55 hypogonadal men 55 subcutaneous insulin 55 NIHSS score 55 calcium supplementation 55 fluvastatin 55 mealtime glucose 55 carotid stenosis 55 peak VO2 55 TAXUS p value 55 postintervention 55 #mg/day [002] 55 nonobstructive CAD 55 active comparator 55 hemoglobin concentration 55 Apidra ® 55 Fasting glucose levels 55 fasting triglycerides 55 chlorthalidone 55 mcg kg 55 serum aminotransferase levels 55 clodronate 55 mg kg dose 55 Serum calcium 55 Unified Parkinson Disease 55 CD4 + cell 55 macrovascular disease 55 #mg/dl 55 hypertension 55 sputum eosinophils 55 IGFBP 55 mineral density 55 tolvaptan 55 Scale EDSS score 55 insulin degludec 55 statin medications 55 plasma leptin 55 NYHA functional class 55 residual platelet reactivity 55 hemoglobin A1C HbA1C 55 creatinine 55 post prandial glucose 55 obese adolescents 55 esomeprazole 55 K DOQI 55 plasma glucose concentration 55 oral glucose tolerance 55 serologically active patients 55 prehypertension 55 TRILIPIX 55 umol L 55 hyperphosphatemia 55 ACR# responses 55 angiotensin converting enzyme 55 adjunctive ABILIFY 55 baseline LDH 55 μg dl 55 PRADAXA 55 sulfonylurea 55 statistical significance p 55 virologic suppression 55 Psoriasis Area 55 nocturnal awakenings 55 MACCE 55 dose statin therapy 55 experienced virologic failure 55 TEAEs 55 acromegalic patients 55 REMICADE monotherapy 55 LDL cholesterol lowering 55 Stop Hypertension DASH diet 55 oral antidiabetic medications 55 Ramipril 55 microvascular disease 55 pulmonary exacerbations 55 lowering LDL cholesterol 55 valsartan 55 CHD mortality 55 fibrinolysis 55 flutamide 55 DAPT 55 UACR 55 glycemic variability 55 nonadherence 55 adenotonsillectomy 55 CI -#.# 55 recurrent wheezing 55 corticosteroid therapy 55 anticoagulation 55 d dimer 55 procalcitonin 55 density BMD 55 aspirin regimen 55 cardiometabolic risk 55 metformin 55 placebo p 55 elevated intraocular pressure 55 virological suppression 55 plasma uric acid 55 Lp PLA2 55 nonfasting triglycerides 55 maximally tolerated doses 55 SELENA SLEDAI score 55 beta blocker therapy 55 mycophenolate mofetil 55 intra ocular pressure 55 calcium intakes 55 lipid abnormalities 55 tertile 55 serum sodium levels 55 receiving golimumab 55 advanced adenoma 55 CIPN 55 systemic corticosteroids 55 N telopeptide 55 teriflunomide 55 thyroid stimulating hormone 55 improves insulin sensitivity 55 SGPT 54 HCTZ 54 eosinophil count 54 caloric intakes 54 timepoints 54 plasma concentrations 54 HSCT 54 vertebral fracture 54 IR Cysteamine 54 hemoglobin Hb 54 saturated fat intake 54 antibody titers 54 #mm Hg 54 metformin monotherapy 54 hypercholesterolaemia 54 thyrotropin 54 YMRS 54 antihypertensive agents 54 μmol l 54 μg dose 54 autoantibody levels 54 resistant hypertension 54 lactate dehydrogenase LDH 54 Lantus R 54 ADCS CGIC 54 carotid intima media 54 bone resorption 54 mean baseline A1C 54 noncardiovascular mortality 54 systemic embolism 54 lamotrigine 54 angiotensin converting enzyme ACE 54 International Normalized Ratio 54 SGOT 54 hepatitis C genotype 54 seroprotection 54 tiotropium 54 salivary cortisol 54 plasma renin activity 54 C Reactive Protein 54 statin 54 peginterferon 54 dosage regimens 54 atazanavir ritonavir 54 prediabetes 54 thyroxine 54 hematologic toxicity 54 abciximab 54 transaminase levels 54 PaO 2 54 TMC# r 54 insulin sensitizing drugs 54 virological failure 54 reintervention 54 LDL lowering 54 repeat revascularization 54 specific antigen PSA 54 #mg dose [003] 54 F2 isoprostanes 54 SUVmax 54 serum testosterone levels 54 Insulin PH# 54 CDAI 54 aldosterone 54 angiographic restenosis 54 pharmacokinetic PK profile 54 CTAP# Capsules 54 mg QD 54 onset diabetes mellitus 54 montelukast 54 molindone 54 cilostazol 54 tamoxifen Nolvadex ® 54 CYPHER Stent 54 prescribed statins 54 orthostatic hypotension 54 severe hypoglycemic 54 subclinical atherosclerosis 54 severe neutropenia 54 LDL triglycerides 54 diuretic chlorthalidone 54 Homocysteine levels 54 telmisartan 54 nephrotoxicity 54 clinically meaningful improvement 54 insulin sensitivity 54 postop 54 aminotransferase ALT 54 DAS# scores 54 dose titration 54 mg/m2 dose 54 azilsartan medoxomil 54 prehypertensive 54 clinically meaningful reductions 54 biochemical recurrence 54 cinacalcet 54 MCyR 54 IBS symptoms 54 plasma homocysteine levels 54 systolic 54 lumbar spine bone 54 folate supplementation 54 timepoint 54 BLLs 54 fosamprenavir 54 β blocker 54 mU L 54 antiplatelet drugs 54 sitagliptin 54 aspartate aminotransferase 54 antiarrhythmic drug 54 eplerenone 54 fingerstick 54 mcg dL 54 posttransplant 54 conventional antipsychotics 54 LEXIVA 54 ACE Inhibitors 54 endometrial hyperplasia 54 thiazide diuretic 54 antidepressant therapy 54 aspirin therapy 54 cotinine levels 54 tHcy concentrations 54 extrapyramidal symptoms 54 fetuin 54 paclitaxel eluting stents 54 HBeAg negative patients 54 carb dieters 54 ml kg 54 flow mediated dilation 54 REYATAZ r arm 54 glucose concentrations 54 depressive symptom 54 -#.# log# 54 % CI #.#-#.# [004] 54 antidiabetic drugs 54 testosterone supplementation 54 inhaled corticosteroids 54 variceal bleeding 54 serum TSH 54 alteplase 54 systemic corticosteroid 54 baseline FEV1 54 hyperglycemia 54 serum parathyroid hormone 54 HIV RNA 54 calorie dieters 54 ml min 54 simvastatin ezetimibe 54 left ventricular systolic 54 ginkgo biloba extract 54 odanacatib 54 IDDM 54 postprandial glycemia 54 intramuscular dose 54 nonfatal MI 54 coronary revascularization 54 diastolic blood pressure 54 bloodpressure 54 endometrial thickness 54 serum triglyceride 54 ritonavir boosted 54 antioxidant intake 54 PKC beta 54 microalbumin 54 prospectively defined 54 recurrent venous thromboembolism 54 Cardiovascular Risk 54 generalized edema 54 NHANES III 54 hepatic fat 54 ACTOplus met 54 subclinical hyperthyroidism 54 HER2 expression 54 diastolic heart 54 dexamethasone Decadron 54 hepatic insulin sensitivity 54 canakinumab 54 BARACLUDE 54 normal ULN 54 cardio respiratory fitness 54 gliclazide 54 periprocedural 54 anakinra 54 oral FTY# 54 8mg/kg 54 HAART regimen 54 nonvertebral fracture 54 Apgar scores 54 glycaemia 54 dose Iluvien 54 mg kg belimumab 54 lipoprotein levels 53 X ULN 53 viral loads 53 thyroid hormone levels 53 adefovir 53 elevated fasting glucose 53 postoperative complication 53 lipid lowering medication 53 -#.# mg dL [001] 53 inadequate glycemic 53 atheroma volume 53 budesonide pMDI 53 ULORIC 53 valsartan amlodipine 53 oral hypoglycemic agent 53 paroxysmal AF 53 TAXUS Express Stent 53 #.#/#.# mm Hg [003] 53 azathioprine 53 ACTOS 53 exacerbations 53 LEXIVA r 53 Complications Trial 53 HIV HCV coinfected 53 Lamictal XR 53 fat oxidation 53 oxycodone IR 53 asthma exacerbation 53 LDL cholesterol concentrations 53 lymphocyte count 53 dalteparin 53 Diovan HCT 53 UPDRS motor 53 Negative Syndrome 53 urine NGAL 53 aminotransferase levels 53 liraglutide 53 patients undergoing CABG 53 Blood Glucose 53 angiotensin receptor blockers 53 index BMI 53 receiving ISENTRESS 53 transaminases 53 postprandial insulin 53 Prehypertension 53 dietary calcium intake 53 IFN beta 53 IIIa inhibitors 53 mcg dl 53 mg BID dose 53 loop diuretics 53 blood lipids 53 serum BDNF 53 rosuvastatin 53 glipizide 53 nmol liter 53 choline intake 53 Baseline characteristics 53 Levemir ® 53 glucose uptake 53 Tekamlo 53 rehospitalizations 53 p = NS 53 warfarin dose 53 thyroglobulin 53 cholesterols 53 plasma renin 53 CYP#C# [001] 53 ALT elevations 53 International Prostate Symptom 53 dose cohort 53 febrile neutropenia 53 carbohydrate diets 53 PSA velocity 53 ginkgo extract 53 #ng/ml 53 tipranavir 53 plus MTX 53 plus dexamethasone 53 elevated LDL 53 BMI percentiles 53 COPD exacerbations 53 achieved PASI 53 LS BMD 53 inhaled steroids 53 NLX P# 53 salmeterol fluticasone 53 pentoxifylline 53 isoprostane 53 TZD 53 normalize blood glucose 53 Triglycerides 53 VAPRISOL 53 shorter telomere length 53 nighttime awakenings 53 bronchodilation 53 MMSE score 53 p = .# [002] 53 comparator arm 53 ibandronate 53 infliximab 53 TNF antagonist 53 potassium sparing diuretics 53 placebo p = 53 carvedilol 53 Proteinuria 53 ramipril 53 HAQ DI 53 sulfonylurea metformin 53 revascularizations 53 teriparatide 53 CR nPR 53 B7 H3 53 R0 resection 53 sweat chloride 53 weekly CSBMs 53 anemia hemoglobin 53 tipranavir r